14 completed, 8 unknown, 4 terminated, 3 recruiting. 31 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 31 | Completed 14, Unknown 8, Terminated 4, Recruiting 3, Not yet recruiting 1, Withdrawn 1 |
Follow Ferinject: new trials by email Literature Review of Ferinject trials Research Report on Ferinject
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency | Phase 4 | Unknown | University of Padova | 258 | 2024-01-15 | 2023-12-15 |
| Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia Venofer 200 MG Per 10 ML Injection, Ferinject - Anemia, Iron Deficiency, Pregnancy Anemia | Phase 4 | Recruiting | Western Galilee Hospital-Nahariya | 200 | 2023-11-02 | 2026-09-11 |
| The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures Ferric carboxymaltose - Hip Fractures, Anemia | Phase 4 | Completed | Istanbul University | 209 | 2023-10-10 | 2025-03-26 |
| The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF) Ferinject, Diet therapy - Chronic Heart Failure, Iron Deficiency, Latent | Phase 4 | Recruiting | Tomsk National Research Medical Center of the Russian Academy of Sciences | 100 | 2023-04-28 | 2026-06-24 |
| Impact of Intravenous Iron on Musculoskeletal Function in Older Adults Ferinject, Ferrous Sulfate 200 MG - Iron Deficiency Anemia | Phase 4 | Not yet recruiting | Liverpool Hope University | 100 | 2023-01-01 | 2023-02-01 |
| Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion Ferinject, Sodium Chloride 0.9% Inj - Myocardial Infarction, Acute | Phase 4 | Recruiting | Wroclaw Medical University | 1000 | 2022-09-22 | 2025-07-30 |
| Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) Ferinject, oral iron - Celiac Disease | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 1 | 2022-07-08 | 2026-07-09 |
| Iron Deficiency as an Ignored Cause of Infertility Ferric Carboxymaltose Injection, NaCl infusion - Iron Deficiency, Infertility | Phase 4 | Unknown | Dextra Fertility Clinic | 62 | 2020-08-17 | 2020-08-12 |
| Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery Ferinject, Normal saline - Hip Fractures | Phase 4 | Unknown | Seoul National University Bundang Hospital | 264 | 2020-07-30 | 2022-06-23 |
| Postoperative Replacement of Intraoperative Iron Losses Ferric carboxymaltose, Crystalloid - Blood Loss Anemia | Phase 4 | Completed | Kepler University Hospital | 134 | 2020-03-06 | 2025-02-04 |
| Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD) Ferric Carboxymaltose Injection [Injectafer], no treatment or oral iron supplementation - Anemia, Peripheral Arterial Occlusive Disease | Phase 4 | Unknown | Biobizkaia Health Research Institute | 240 | 2019-08-15 | 2023-01-05 |
| The Iron and Muscle Study Ferinject, Placebo: NaCl (sodium chloride 0.9%) - CKD Stage 3, CKD Stage 4 | Phase 4 | Completed | King's College Hospital NHS Trust | 75 | 2019-04-26 | 2022-03-02 |
| Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting Ferinject, Normal Saline Flush - Coronary Artery Disease | Phase 4 | Unknown | Yonsei University | 100 | 2019-02-10 | 2021-05-24 |
| A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease Iron Isomaltoside, Ferric Carboxymaltose - IBD | Phase 4 | Completed | Pharmacosmos A/S | 97 | 2018-05-23 | 2021-02-21 |
| Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD Sodium Chloride 0.9% Intravenous Solution, Ferinject - Renal Anemia, Iron Toxicity | Phase 4 | Unknown | Carol Davila University of Medicine and Pharmacy | 40 | 2017-09-20 | 2022-08-16 |
| Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency ferric carboxymaltose, Normal saline 0.9% - Iron Deficiency, Heart Failure | Phase 4 | Completed | Vifor (International) Inc. | 1132 | 2017-04-03 | 2021-06-18 |
| Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency Standard of care, Iron Carboxymaltose - Heart Failure | Phase 4 | Withdrawn | Tel-Aviv Sourasky Medical Center | 2016-12-14 | 2018-02-28 | |
| The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery Ferinject, Placebo - Anemia | Phase 4 | Unknown | Rambam Health Care Campus | 200 | 2016-11-01 | 2016-10-28 |
| Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery Ferric carboxymaltose, Placebo - Anaemia | Phase 4 | Completed | Bayside Health | 955 | 2016-07-15 | 2026-01-02 |
| A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer Iron Isomaltoside 1000, Ferric Carboxymaltose - Anemia, Iron-Deficiency | Phase 4 | Completed | Universität des Saarlandes | 26 | 2016-07-01 | 2020-11-30 |
Showing 20 of 31. Sign in to see all of them.
Anemia (15) · Iron Deficiencies (11) · Anemia, Iron-Deficiency (8) · Heart Failure (4) · Colorectal Neoplasms (2) · Hip Fractures (2) · Postoperative Complications (2) · Adenocarcinoma (1) · Celiac Disease (1) · Coronary Artery Disease (1) · Gastrointestinal Hemorrhage (1) · Heart Failure, Systolic (1) · Hemorrhage (1) · Infertility (1) · Lymphoproliferative Disorders (1)
University of Zurich (2) · Vifor Pharma (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Assistance Publique - Hôpitaux de Paris (1) · Bayside Health (1) · Biobizkaia Health Research Institute (1) · Carol Davila University of Medicine and Pharmacy (1) · Catharina Ziekenhuis Eindhoven (1) · Dextra Fertility Clinic (1) · Istanbul University (1) · Kepler University Hospital (1) · King's College Hospital NHS Trust (1) · Liverpool Hope University (1) · Maastricht University Medical Center (1) · National University Hospital, Singapore (1)
Netherlands (5) · Israel (3) · United Kingdom (3) · Austria (2) · Denmark (2) · France (2) · Poland (2) · Romania (2) · Singapore (2) · South Korea (2) · Spain (2) · Switzerland (2) · Argentina (1) · Australia (1) · Brazil (1)
Alla A. Garganeeva, M.D. (1) · Ana Apodaka Diez, MD (1) · Annika Tulenheimo-Silfvast, M.D (1) · Austin G Acheson, MD FRCS (1) · Bernard Favrat (1) · Carolyn SP Lam, MBBS, MRCP (UK) (1) · Claudio Bassetti, Professor (1) · Cristina Capusa, Assoc. Prof. (1) · Danilo Fliser, MD (1) · Donat R Spahn, Prof MD (1) · Federico Capone, MD (1) · Gabriel Mircescu, Professor (1) · Gunnar Heine, MD (1) · Hendrik Vilstrup, Professor (1)
PMID 20124051, PMID 22353604, PMID 24251969, PMID 24751822, PMID 26123286, PMID 27195774, PMID 27624208, PMID 31036337, PMID 31668348, PMID 31883356, PMID 32402684, PMID 32654663, PMID 33197395, PMID 34006287, PMID 34079413, PMID 34088733, PMID 36863386, PMID 37051919, PMID 37382961, PMID 37592272, PMID 37838604, PMID 38874697, PMID 42618081
2019 (2), 2009 (1), 2014 (1), 2015 (1), 2016 (1), 2018 (1)